This marks the first major regulatory approval of a vaccine developed by Janssen
News
ViiV selects projects for HIV/COVID-19 response fund
ViiV received more than 400 applications from across the world, with eligible submissions coming from Africa, Asia, Europe, South America and the US
US approves Bavencio for bladder cancer
In a clinical trial, Bavencio maintenance treatment extended median overall survival by 50% over standard of care
CMA imposes £1.2m fines for price-fixing in private eye care
Consultant ophthalmologists at Spire hospital conspired to fix prices for private consultations
Vertex signs ‘landmark’ deal with NHS for CF therapy
CF patients in England will be among the first in Europe to benefit from access to Kaftrio, if the medicine is approved by the EC
Cambridge spin-out PharmEnable raises £1.8m for drug discovery
The funds will enable in-house drug discovery across a number of therapeutic areas including cancer and neurodegeneration
Pfizer links with SidekickHealth for digital health solution
The collaboration hopes to empower patients to take more control of their own health
US nod for Roche’s breast cancer combo
The therapy marks Roche’s first combination of two monoclonal antibodies administered in a single subcutaneous injection
CR UK calls on Scottish gov to ‘urgently’ restart cancer trials
Almost all cancer trials in Scotland are on hold amid the coronavirus pandemic
MHRA issues consent for RedHill Bioharma’s Yeliva trial
The study will assess the potential of the drug in patients hospitalised with severe SARS-CoV-2 infection and pneumonia
Obesity linked to higher risk of dementia
UCL researchers find a 31% increased risk of dementia in those with high BMI
Successful Elocta bid should widen access to the drug in the UK
Through an agreement with the NHS and Sobi UK, people living with haemophilia A in the UK will have increased access to Elocta following a successful bid in the UK’s Haemophilia A Tender
EC clears new class of anaemia therapy
BMS’ Reblozyl is the first and only erythroid maturation agent approved in the EU
Eight medicines leap towards EU approval
The recommendations include a conditional approval for Gilead’s Veklury (remdesivir) for COVID-19
MSD’s Keytruda bags approval for new skin cancer indication
In trials Keytruda showed ‘meaningful efficacy’ with an objective response rate of 34%
